UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center
Davis, California, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms | neoplasm | Active, not recruiting | Phase 2 | 2026-09-01 | NCT06788938 |